Lynn Mason appointed CEO for IVI RMA America

Basking Ridge-based IVI RMA America, the largest reproductive medicine group in the world, recently announced the appointment of Lynn Mason as CEO. She will oversee the North American operations as well as growth initiatives in support of bringing better fertility outcomes to more patients across the U.S. and Canada.

“Lynn is a talented, proven leader who has made her mark on the ever-changing health care environment by working as a transformative executive in both large and small organizations, delivering quality care and a great patient experience,” Javier Sanchez Prieto, CEO of IVI RMA, said. “We’re excited for Lynn’s leadership as we continue to foster a patient-first approach while delivering industry-leading fertility solutions.”

Prior to joining IVI RMA America, Mason served for four years as CEO and president of Broadstep Behavioral Health, a leading provider of behavioral health and supportive living services for children and adults with intellectual and developmental disabilities, mental illness and co-occurring disorders. During her tenure at Broadstep, the company more than doubled in size in three years, expanding from four to seven states. Earlier in her career, Mason held senior leadership roles with increasing responsibility in health care organizations, including ChenMed, Care Services, DaVita Kidney Care and DaVita RX, and United Allergy Services.

Mason currently serves on the boards of directors of nonprofits Shoes-That-Fit and the American Heart Association – Go Red for Women. She also contributes to primary care and behavioral health by serving on the boards of directors for ConvenientMD and Stella Behavioral Health and is an active member of the Stanford Women on Boards and the Stanford Black Alumni Association.

Mason earned her B.S.B.A. in finance and accounting from Washington University in St. Louis and her MBA from Stanford University’s Graduate School of Business.

“IVI RMA has a stellar reputation for the industry’s best outcomes, most innovative R&D platform and sharpest talent, and I am thrilled and honored to join as CEO for America,” Mason said. “I’m eager to support our physician leaders in expanding our presence and strengthening our culture to make IVI RMA America the natural first choice for patients, physicians and medical partners.”

“The team and I look forward to Lynn bringing a fresh and energized perspective to our business and complementing our scientific leaders,” Dr. Thomas Molinaro, medical director, IVI RMA America, said. “Her experience across multiple channels of health care delivery will serve us well as we position the organization for future growth and continued reproductive excellence.”